Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/07/2010WO2010114805A1 Methods of treating cancer with phenformin
10/07/2010WO2010114801A1 Oral formulations of diphenylsulfonamide endothelin and angiotensin ii receptor agonists to treat elevated blood pressure and diabetic nephropathy
10/07/2010WO2010114780A1 Inhibitors of akt activity
10/07/2010WO2010114779A1 Controlled exotherm of cyanoacrylate formulations
10/07/2010WO2010114770A1 Polymer-agent conjugates, particles, compositions, and related methods of use
10/07/2010WO2010114762A1 Colorimetric-oxycarbonyl protecting groups for use in organic syntheses
10/07/2010WO2010114726A1 Aminobenzotriazole derivatives
10/07/2010WO2010114622A1 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
10/07/2010WO2010114563A1 Metabolites of k201 (jtv-519) (4- [3-{1- (4- benzyl) piperidinyl} propionyl] -7 -methoxy 2, 3, 4, 5-tetrahydro-1,4-benzothiazepine monohydrochloride
10/07/2010WO2010114533A1 Anti-biofilm carbonate compounds for use in oral care compositions
10/07/2010WO2010114494A1 8-substituted-2-morpholino purines for use as pi3k and/or mtor inhibitors in the treatment of proliferative disorders
10/07/2010WO2010114493A1 Lanthanide metal complexes useful in treating cancer
10/07/2010WO2010114484A1 Pyrimidine substituted purine compounds as kinase (s) inhibitors
10/07/2010WO2010114476A1 Novel derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
10/07/2010WO2010114473A1 Novel steroidal[3,2-c]pyrazol derivatives with glucocorticoid activity
10/07/2010WO2010114472A1 Pharmaceutical composition comprising a steroidal[3,2-c]pyrazole derivative and a second pharmaceutically active compound
10/07/2010WO2010114471A1 Novel amide derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
10/07/2010WO2010114425A2 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum
10/07/2010WO2010114404A1 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
10/07/2010WO2010114396A1 Medicament uptake
10/07/2010WO2010114319A2 Composition for bone regeneration
10/07/2010WO2010114215A2 Composition for preventing or treating obesity, dyslipidemia, fatty liver or insulin resistance syndrome, comprising camphor as an active ingredient
10/07/2010WO2010114181A1 Acrylamide compounds and the use thereof
10/07/2010WO2010114179A1 3-[1,4]oxazepane-4-pyrimidone derivatives
10/07/2010WO2010114163A1 Compositions comprising 2, 4, 6-triamino-1, 3, 5-triazine derivatives for treatment of schizophrenia
10/07/2010WO2010114162A1 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
10/07/2010WO2010114129A1 T cell receptor and nucleic acid encoding the receptor
10/07/2010WO2010114121A1 Aqueous gel base and aqueous gel plaster
10/07/2010WO2010114013A1 Polyion complex of double-stranded ribonucleic acid
10/07/2010WO2010113984A1 Liposome composition
10/07/2010WO2010113983A1 Method for producing liposome composition
10/07/2010WO2010113960A1 Agent for inhibiting thickening of peritoneal membrane
10/07/2010WO2010113958A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases
10/07/2010WO2010113957A1 Pharmaceutical composition for treating or preventing glaucoma
10/07/2010WO2010113952A1 Muscarinic receptor antagonist
10/07/2010WO2010113942A1 Indolizine derivative and use thereof for medical purposes
10/07/2010WO2010113925A1 Composition for alleviating ultraviolet radiation-induced damage
10/07/2010WO2010113900A1 Production method for ubiquinone powder for use in preparations and product thereof
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113848A1 Isothiourea derivative or isourea derivative having bace1 inhibitory activity
10/07/2010WO2010113844A1 Rnai molecule for thymidylate synthase and use thereof
10/07/2010WO2010113841A1 Orally disintegrating coated tablet
10/07/2010WO2010113840A1 Solid pharmaceutical composition containing amorphous body of solifenacin
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113785A1 Method for producing sugar composition containing definite amount of target hexose and having sugar composition ratio different from starting sugar material, and use of sugar composition thus produced
10/07/2010WO2010113725A1 Tricyclic condensed heterocyclic compound, method for producing same, and use thereof
10/07/2010WO2010113631A1 Agent for amelioration or prevention of metabolic syndrome
10/07/2010WO2010113627A1 Highly sensitive detection method for highly virulent oral cavity bacteria
10/07/2010WO2010113590A1 Skin-whitening agent and cosmetic method for whitening skin
10/07/2010WO2010113507A1 Double-stranded molecule inhibiting the expression of gpc3
10/07/2010WO2010113498A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
10/07/2010WO2010113458A1 Method for manufacturing benzodiazepine derivative
10/07/2010WO2010113325A1 Pectin-containing jelly preparation
10/07/2010WO2010113324A1 Pectin-containing jelly preparation
10/07/2010WO2010113225A1 Riluzole-containing transdermal patch
10/07/2010WO2010113168A1 A bio-stabilized resveratrol formulation
10/07/2010WO2010113109A1 Treatment of tinnitus and associated auditory dysfunctions
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112965A1 Isolation coating of diclofenac tablets
10/07/2010WO2010112942A1 Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
10/07/2010WO2010112936A1 P38map kinase inhibitor
10/07/2010WO2010112874A1 Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives
10/07/2010WO2010112865A1 5-ht receptor modulating compounds
10/07/2010WO2010112749A1 Solid lipid nanoparticles encapsulating minoxidil, and aqueous suspension containing same
10/07/2010WO2010112615A1 Lysine derivatives functionalised with lipids
10/07/2010WO2010112597A1 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
10/07/2010WO2010112578A1 4 -isopropyl-3-methylphenol for the treatment of inflammation
10/07/2010WO2010112577A1 Antibacterial composition comprising 4 -isopropyl-3-methylpheno and zinc ions
10/07/2010WO2010112570A1 Dialysis solution
10/07/2010WO2010112547A1 Dialysis precursor composition
10/07/2010WO2010112541A1 Pharmaceutical composition containing a limus family immunosuppressive macrolide
10/07/2010WO2010112538A1 A multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
10/07/2010WO2010112529A1 Low dose pipamperone in treating mood disorders
10/07/2010WO2010112520A1 Spiro derivatives for the modulation of stearoyl-coa desaturase
10/07/2010WO2010112510A1 Use of flavonoids to increase the bioavailability of hesperetin
10/07/2010WO2010112497A1 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
10/07/2010WO2010112486A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112485A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112484A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
10/07/2010WO2010112482A1 A process for dimethylation of active methylene groups
10/07/2010WO2010112475A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators
10/07/2010WO2010112461A1 Oxadiazole derivatives
10/07/2010WO2010112437A1 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
10/07/2010WO2010112429A1 Reduction of risk of obesity
10/07/2010WO2010112413A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/07/2010WO2010112411A1 Co-crystal of etravirine and nicotinamide
10/07/2010WO2010112406A1 Ready-to-use, stable suspension of partially amorphous carotenoid particles
10/07/2010WO2010112362A1 Dietary supplement comprising alpha keto acids for supporting diabetes therapy
10/07/2010WO2010112256A1 Satiety-inducing composition
10/07/2010WO2010112221A1 Pharmaceutical compositions comprising memantine
10/07/2010WO2010112203A1 Pills comprising dapoxetin and dry processing methods for the production thereof
10/07/2010WO2010112124A1 Autotaxin inhibitors
10/07/2010WO2010112116A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010WO2010112113A1 Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid
10/07/2010WO2010112093A1 Benzoxazoles for the treatment of duchenne muscular dystrophy
10/07/2010WO2010112092A1 Compounds for treatment of duchenne musculary dystrophy
10/07/2010WO2010112091A1 Compounds for treatment of duchenne muscular dystrophy
10/07/2010WO2010112071A1 Combination of astaxanthin, antioxidants and colouring agents with sunscreen effect to be administered orally
10/07/2010WO2010112060A1 Nutriment for use for accelerated physiological perfomance enhancement
10/07/2010WO2010111951A1 Crystals of prasugrel hydrobromate
1 ... 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 ... 7860